鲸蜡醇硫酸酯DEA盐 | 51541-51-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 鲸蜡醇硫酸酯DEA盐
• 英文名称: Bis(2-hydroxyethyl)ammonium hexadecyl sulphate
• 英文别名: bis(2-hydroxyethyl)azanium;hexadecyl sulfate
• CAS: 51541-51-6
• 化学式: C20H45NO6S
• 分子量: 427.6
• InChiKey: PJDFMXWUFDUYTG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.85
• 重原子数：
  28
• 可旋转键数：
  20
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  125
• 氢给体数：
  4
• 氢受体数：
  7

文献信息

• CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
  申请人：LICHTER Jay

  公开号：US20100036000A1

  公开（公告）日：2010-02-11

  Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

  本文公开了用抗微生物药物组合物和制剂治疗耳疾或病症的组合物和方法，通过将这些组合物和制剂直接应用于或通过灌注进入目标耳结构，局部治疗患有耳疾或病症的个体。
• AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS
  申请人：LICHTER Jay

  公开号：US20090306225A1

  公开（公告）日：2009-12-10

  Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.

  本文公开了使用免疫调节剂和耳压调节剂治疗耳部疾病的组合物和方法。在这些方法中，通过将免疫调节剂和/或耳压调节剂组合物和配方直接应用于耳媒介和/或耳内靶区，或通过灌注进入耳媒介和/或耳内结构，局部给患有耳部疾病的个体进行治疗。
• Controlled Release Antimicrobial Compositions and Methods for the Treatment of Otic Disorders
  申请人：Otonomy, Inc.

  公开号：US20150150793A1

  公开（公告）日：2015-06-04

  Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

  本文公开了一种使用抗微生物剂组合物和制剂局部治疗患有耳疾或状况的个体的方法和组合物，通过将这些组合物和制剂直接应用于或通过灌注进入目标耳结构。
• Auris Formulations for Treating Otic Diseases and Conditions
  申请人：Otonomy, Inc.

  公开号：US20160228357A1

  公开（公告）日：2016-08-11

  Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods, the auris compositions and formulations are administered locally to an individual afflicted with an otic disorder, through direct application of the immunomodulating and/or auris pressure modulating compositions and formulations onto the auris media and/or auris interna target areas, or via perfusion into the auris media and/or auris interna structures.

  本文介绍了使用免疫调节剂和耳压调节剂治疗耳部疾病的组合物和方法。在这些方法中，通过直接将免疫调节剂和/或耳压调节剂组合物和配方局部应用于患有耳部疾病的个体的耳媒体和/或耳内靶区，或通过灌注到耳媒体和/或耳内结构中。
• HYDROPHILIC POLYMER-SILICATE MINERAL COMPOSITE AND ITS USE
  申请人：SHISEIDO COMPANY LIMITED

  公开号：EP0450094A1

  公开（公告）日：1991-10-09

  A composite comprising a carboxylated hydrophilic polymer and a water-swellable silicate mineral and having in its infrared absorpion spectrum a new absorption at 1000 to 1300 cm⁻¹ not assignable to any of the starting materials, and a pharmaceutical composition and a cosmetic composition comprising the same.

  一种由羧基化亲水性聚合物和水溶性硅酸盐矿物组成的复合材料，其红外吸收光谱在 1000 至 1300 cm-¹ 处有新的吸收，而这种新的吸收不属于任何一种起始材料，以及一种包含该复合材料的药物组合物和化妆品组合物。